Dell Technologies Inc. (NYSE: DELL): What EMC’s $984.3 m Air Force award means for defense IT strategy
Read More Pharma Industry News VERAXA Biotech seals $1.64bn SPAC merger to launch Nasdaq oncology powerhouse Find out how VERAXA Biotech’s $1.64B Nasdaq listing is set to redefine cancer treatment with next-gen antibody therapies. byPallavi MadhirajuApril 25, 2025